BRCA1 and breast carcinoma: Through testing the entire sequences of BRCA1/2 genes with improved methodology and techniques, we estimate the combined prevalence of BRCA1/2 pathogenic variants among unselected breast cancer patients in Sweden to be closer to 2%.